New program aims to slash heart risk by optimizing cholesterol in UAE patients
NCT ID NCT07034690
First seen Jan 04, 2026 · Last updated May 20, 2026 · Updated 19 times
Summary
This study tests whether a targeted lipid optimization program helps adults in Abu Dhabi who are at high risk for heart disease reach their LDL (bad) cholesterol goals. About 326 participants will be randomly assigned to the program or usual care. The goal is to see if the program improves cholesterol control and reduces cardiovascular risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Novartis Investigative Site
RECRUITINGAbu Dhabi, United Arab Emirates
Conditions
Explore the condition pages connected to this study.